| Year |
Citation |
Score |
| 2015 |
Loriot C, Domingues M, Berger A, Menara M, Ruel M, Morin A, Castro-Vega LJ, Letouzé É, Martinelli C, Bemelmans AP, Larue L, Gimenez-Roqueplo AP, Favier J. Deciphering the molecular basis of invasiveness in Sdhb-deficient cells. Oncotarget. PMID 26460615 DOI: 10.18632/Oncotarget.5106 |
0.616 |
|
| 2015 |
Castro-Vega LJ, Letouzé E, Burnichon N, Buffet A, Disderot PH, Khalifa E, Loriot C, Elarouci N, Morin A, Menara M, Lepoutre-Lussey C, Badoual C, Sibony M, Dousset B, Libé R, et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nature Communications. 6: 6044. PMID 25625332 DOI: 10.1038/Ncomms7044 |
0.645 |
|
| 2014 |
Hadoux J, Favier J, Scoazec JY, Leboulleux S, Al Ghuzlan A, Caramella C, Déandreis D, Borget I, Loriot C, Chougnet C, Letouzé E, Young J, Amar L, Bertherat J, Libé R, et al. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. International Journal of Cancer. 135: 2711-20. PMID 24752622 DOI: 10.1002/Ijc.28913 |
0.633 |
|
| 2013 |
Letouzé E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, Buffet A, Marcaillou C, Bertherat J, Amar L, Rustin P, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell. 23: 739-52. PMID 23707781 DOI: 10.1016/J.Ccr.2013.04.018 |
0.701 |
|
| 2012 |
Burnichon N, Buffet A, Parfait B, Letouzé E, Laurendeau I, Loriot C, Pasmant E, Abermil N, Valeyrie-Allanore L, Bertherat J, Amar L, Vidaud D, Favier J, Gimenez-Roqueplo AP. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Human Molecular Genetics. 21: 5397-405. PMID 22962301 DOI: 10.1093/Hmg/Dds374 |
0.67 |
|
| 2012 |
Loriot C, Burnichon N, Gadessaud N, Vescovo L, Amar L, Libé R, Bertherat J, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP, Favier J. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. The Journal of Clinical Endocrinology and Metabolism. 97: E954-62. PMID 22492777 DOI: 10.1210/Jc.2011-3437 |
0.685 |
|
| 2012 |
Hadoux J, Leboulleux S, Al Ghuzlan A, Borget I, Loriot C, Chougnet C, Caramella C, Young J, Dumont F, Deschamps F, Favier J, Schlumberger M, Gimenez-Roqueplo A, Baudin E. Traitement par temozolomide des phéochromocytomes/paragangliomes métastatiques (PPM) progressifs : la faible expression de MGMT et la mutation SDHB prédisent l’efficacité Annales D'Endocrinologie. 73: 253-254. DOI: 10.1016/J.Ando.2012.07.072 |
0.402 |
|
| 2011 |
Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD, Darmoul D. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. The American Journal of Pathology. 179: 2625-36. PMID 21907696 DOI: 10.1016/J.Ajpath.2011.07.016 |
0.323 |
|
| Show low-probability matches. |